Within a breast cancer biobank research study, ten germline mutations in BRCA1 (n = 5) or BRCA2 (n = 5) were incidentally revealed in study participants that were themselves not aware of their mutation carrier status, 5–7 years after they had been included in the study. The gene discussed is BRCA2; the disease is breast cancer.